These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18378545)

  • 1. Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study.
    Strasser F; Demmer R; Böhme C; Schmitz SF; Thuerlimann B; Cerny T; Gillessen S
    Oncologist; 2008 Mar; 13(3):337-46. PubMed ID: 18378545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
    Halyard MY; Jatoi A; Sloan JA; Bearden JD; Vora SA; Atherton PJ; Perez EA; Soori G; Zalduendo AC; Zhu A; Stella PJ; Loprinzi CL
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1318-22. PubMed ID: 17394940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias.
    Jacobson SD; Loprinzi CL; Sloan JA; Wilke JL; Novotny PJ; Okuno SH; Jatoi A; Moynihan TJ
    J Support Oncol; 2003; 1(4):274-8. PubMed ID: 15334869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of dysgeusia associated with chemotherapy for cancer].
    Ishikawa T; Morita J; Kawachi K; Tagashira H
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1049-54. PubMed ID: 23986049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy.
    Peterson DE; Jones JB; Petit RG
    Cancer; 2007 Jan; 109(2):322-31. PubMed ID: 17154160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a chemotherapy-induced taste alteration scale.
    Kano T; Kanda K
    Oncol Nurs Forum; 2013 Mar; 40(2):E79-85. PubMed ID: 23448748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taste alteration in breast cancer patients treated with taxane chemotherapy: experience, effect, and coping strategies.
    Speck RM; DeMichele A; Farrar JT; Hennessy S; Mao JJ; Stineman MG; Barg FK
    Support Care Cancer; 2013 Feb; 21(2):549-55. PubMed ID: 22864536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
    Vahdat L; Papadopoulos K; Lange D; Leuin S; Kaufman E; Donovan D; Frederick D; Bagiella E; Tiersten A; Nichols G; Garrett T; Savage D; Antman K; Hesdorffer CS; Balmaceda C
    Clin Cancer Res; 2001 May; 7(5):1192-7. PubMed ID: 11350883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.
    Beer TM; Ryan CW; Venner PM; Petrylak DP; Chatta GS; Ruether JD; Redfern CH; Fehrenbacher L; Saleh MN; Waterhouse DM; Carducci MA; Vicario D; Dreicer R; Higano CS; Ahmann FR; Chi KN; Henner WD; Arroyo A; Clow FW;
    J Clin Oncol; 2007 Feb; 25(6):669-74. PubMed ID: 17308271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of smoking on the pharmacokinetics and toxicity profiles of taxane therapy.
    de Graan AJ; Loos WJ; Friberg LE; Baker SD; van der Bol JM; van Doorn L; Wiemer EA; van der Holt B; Verweij J; Mathijssen RH
    Clin Cancer Res; 2012 Aug; 18(16):4425-32. PubMed ID: 22645049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer.
    Rugo HS; Stopeck AT; Joy AA; Chan S; Verma S; Lluch A; Liau KF; Kim S; Bycott P; Rosbrook B; Bair AH; Soulieres D
    J Clin Oncol; 2011 Jun; 29(18):2459-65. PubMed ID: 21555686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.
    Kozelsky TF; Meyers GE; Sloan JA; Shanahan TG; Dick SJ; Moore RL; Engeler GP; Frank AR; McKone TK; Urias RE; Pilepich MV; Novotny PJ; Martenson JA;
    J Clin Oncol; 2003 May; 21(9):1669-74. PubMed ID: 12721240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind study of the influences of eszopiclone on dysgeusia and taste function.
    Doty RL; Treem J; Tourbier I; Mirza N
    Pharmacol Biochem Behav; 2009 Dec; 94(2):312-8. PubMed ID: 19772869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
    Vasey PA; Jayson GC; Gordon A; Gabra H; Coleman R; Atkinson R; Parkin D; Paul J; Hay A; Kaye SB;
    J Natl Cancer Inst; 2004 Nov; 96(22):1682-91. PubMed ID: 15547181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
    Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
    Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.
    Azzoli CG; Krug LM; Gomez J; Miller VA; Kris MG; Ginsberg MS; Henry R; Jones J; Tyson L; Dunne M; Pizzo B; Farmer A; Venkatraman E; Steffen R; Sirotnak FM
    Clin Cancer Res; 2007 May; 13(9):2692-8. PubMed ID: 17473201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.
    Nuzzo F; Morabito A; De Maio E; Di Rella F; Gravina A; Labonia V; Landi G; Pacilio C; Piccirillo MC; Rossi E; D'Aiuto G; Thomas R; Gori S; Colozza M; De Placido S; Lauria R; Signoriello G; Gallo C; Perrone F; de Matteis A
    Crit Rev Oncol Hematol; 2008 May; 66(2):171-80. PubMed ID: 18160303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors.
    Lokich J
    Cancer; 2000 Dec; 89(11):2309-14. PubMed ID: 11147602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.